Antibiotic CoNS (N=44) S. aureus
(N=6)
Enterococcus (N=4) Acinetobacter (N=4) E. coli (N=2)
P 24 (54.5%) 3 (50%) 1 (25%) - -
Ox 24 (54.5%) 3 (50%) 1 (25%) - -
G 16(36.3%) 2 (33.3%) 1 (25%) 2(50%) 1 (50%)
CF 16(36.3%) 2 (33.3%) 1 (25%) 2 (50%) 1 (50%)
LE 5(11.3%) 1 (16.6%) - 2 (50%) -
E 16(36.3%) 2 (33.3%) 1 (25%) 2 (50%) 1 (50%)
Co 16(36.3%) 2 (33.3%) 1 (25%) 2 (50%) -
CD 16(36.3%) 2 (33.3%) 1 (25%) 2 (50%) -
T 16(36.3%) 2 (33.3%) 1 (25%) - -
VA 0% - 1 (25%) - -
CA - - - 2(50%) 1(50%)
PIT - - - 1(25%) 0%
I - - - 1(25%) 1(50%)
MRP - - - 1(25%) 0%
TIG - - - 0% 0%
TE 0% 0% 0% - -
CL - - - 0% 0%
LZ 0% 0% 0% - -
NT - - - 1(25%) 0%
AK - - - 2(50%) 1(50%)
P-penicillin, OX- Oxacillin, G-Gentamicin, CF- Ciprofloxacin, LE- Levofloxacin, E- Erythromicin, CO- Cotrimoxazole, CD- Clindamycin, T- Tetracyclin, VA- Vancomycin, CACeftazidime, PIT- Piperacilline-Tazobactam, I-Imepenem, MRP- Meropenem, TIG-Tigecycline, CL- Colistin, LZ-Linezolid, NT- Netilmicin, AK- Amikacin
Table 2: Antibiotic resistance profile as assessed by disc diffusion methods of different bacterial strains isolated from hands of health care workers.